
Trizunaglim 2mg/500mg/15mg Tablet
Marketer
Zunarsh Lifesciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Trizunaglim 2mg/500mg/15mg Tablet
Combiflex (2mg/500mg/15mg) tablets are a triple-action formulation managing blood glucose. In conjunction with diet and exercise, this medication improves glycemic control in adult type 2 diabetics. It enhances insulin efficiency, thus reducing blood sugar. Dosage and duration for Combiflex should strictly adhere to your physician's instructions. Administer with food to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dose. Overdosage can cause hypoglycemia. Concurrent use with other antidiabetics, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or cardiac issues should be disclosed to your doctor before commencing treatment, as should pregnancy or breastfeeding. Renal function tests will be conducted prior to treatment initiation. Limit alcohol consumption to minimize potential adverse effects.
Uses of Trizunaglim 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Trizunaglim 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Trizunaglim 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
Common Side effects of Trizunaglim 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Trizunaglim 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Trizunaglim 2mg/500mg/15mg Tablet whole; do not chew, crush, or divide it. Consume this medication with food.
How Trizunaglim 2mg/500mg/15mg Tablet works:
The combined antidiabetic medication Trizunaglim (2mg/500mg/15mg tablet) contains glimepiride, metformin, and pioglitazone. These three agents, each operating via distinct pathways, synergistically manage blood glucose when monotherapy or dual-drug regimens prove insufficient. Glimepiride (a sulfonylurea) stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin (a biguanide) reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone (a thiazolidinedione) further boosts insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Trizunaglim 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Trizunaglim 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Trizunaglim 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with impaired kidney function, Trizunaglim 2mg/500mg/15mg tablets require careful administration and potential dosage modification. Patients with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Trizunaglim 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Trizunaglim 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Trizunaglim 2mg/500mg/15mg Tablet :
Should you forget a Trizunaglim 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Trizunaglim 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
